ProCHO® 5 Protein-free CHO Medium Powder kit with HEPES and 0.1% Pluronic® F-68, without L-Glutamine, phenol red, hypoxanthine or thymidine, 500 L (NAO)
ProCHO® 5, protein free CHO medium, with HEPES and 0.1% Pluronic® F-68, without L-glutamine, phenol red, hypoxanthine or thymidine, 50L powder kit (NAO)
ProCHO® 5, protein free CHO medium, with HEPES and 0.1% Pluronic® F-68, without L-Glutamine, phenol red, hypoxanthine or thymidine, 10 L powder kit (NAO)
ProCHO® 5 Protein-free CHO Medium, basal powder, 50 L (NAO)
ProCHO® 5 Protein-free CHO Medium, basal powder, 500 L (NAO)
ProCHO® 5 protein free CHO medium, with HEPES and 0.1% Pluronic® F-68, without L-Glutamine, phenol red, hypoxanthine or thymidine, 1 L (NAO)
ProCHO® 4 Protein-free CHO Medium with 0.1% Pluronic® F-68, without L-glutamine, phenol red, hypoxanthine or thymidine, 1 L.
ProCHO® 4 Protein-free CHO Medium with 0.1% Pluronic® F-68, without L-glutamine, phenol red, hypoxanthine or thymidine, 1 L
Pro293TMa Serum-free Medium, chemically defined for adherent cells, without L-glutamine or phenol red with 0.1% Pluronic® F-68, 1 L
Pro293sTM Serum-free Medium, chemically defined, for suspension cells, without L-glutamine, phenol red, galactose or Pluronic® F-68, 1 L
-
References - X-Vivo™Overview of relevant references
-
X-VIVO Reference Guide 2025A curated list of peer-reviewed articles related to X-VIVO RUO media as used for culturing different primary cells and is a resource for potential consumers to find scientific data.
-
Instructions for Use – TheraPEAK® X-VIVO® Cell Culture MediumInstructions for how to use the X-VIVO® Media Series
-
A Novel In Vitro Liver Cell Culture Flow System Allowing Long-Term Metabolism and Hepatotoxicity Studies]Manuscript published in Applied In Vitro Toxicology journal describes improvement of CYP450 phenotype of primary cryopreserved hepatocytes using Quasi Vivo® System
-
TheraPEAK® X-VIVO® Hematopoietic Cell Culture MediumSerum-free, GMP produced medium for cell therapy applications
-
Formulation - Leibovitz Modified Medium (L-15)Composition of L-15 (12-669)
-
A Non-Viral Method for Modifying and Expanding Primary T CellsLearn how Lonza’s Cocoon® Platform, 4D-Nucleofector® LV Unit and X-VIVO® 15 Medium are integrated to enable non-viral genetic modification and subsequent expansion of primary T cells in a functionally-closed, automated workflow.
-
Formulation - Leibovitz Medium (L-15)Components present in L-15 (12-700).
-
Primary Normal Human Cells and MediaIn Vivo Relevance. In Vitro Results. Updated and revised cell content.
-
TechSheet – L-15 Leibovitz MediumHow to use L-15 Medium